Hypha Labs annual ebitda
2014
2015
2016
2017
2018
2019
2020
2021
2022
Hypha Labs EBITDA Growth & History (FUNI)
Hypha Labs's calculated EBITDA was −$946,314 for fiscal 2022.
View full Hypha Labs company overviewHypha Labs annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-09-30 | −$946,314 | −$465,999 | — |
| 2021 | 2021-09-30 | −$480,315 | $1.4M | — |
| 2020 | 2020-09-30 | −$1.9M | −$286,498 | — |
| 2019 | 2019-09-30 | −$1.6M | −$101,018 | — |
| 2018 | 2018-09-30 | −$1.5M | −$437,802 | — |
| 2017 | 2017-09-30 | −$1.0M | $1.6M | — |
| 2016 | 2016-09-30 | −$2.6M | $719,839 | — |
| 2015 | 2015-09-30 | −$3.4M | −$1.0M | — |
| 2014 | 2014-09-30 | −$2.3M | — | — |
Hypha Labs quarterly ebitda
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2023 | 2022-12-31 | −$71,577 | $87,544 | — |
| Q4 2022 | 2022-09-30 | −$486,315 | −$264,065 | — |
| Q3 2022 | 2022-06-30 | −$57,016 | $14,614 | — |
| Q2 2022 | 2022-03-31 | −$243,862 | −$322,426 | — |
| Q1 2022 | 2021-12-31 | −$159,121 | $105,878 | — |
| Q4 2021 | 2021-09-30 | −$222,250 | $610,934 | — |
| Q3 2021 | 2021-06-30 | −$71,630 | $314,212 | — |
| Q2 2021 | 2021-03-31 | $78,564 | $587,537 | — |
| Q1 2021 | 2020-12-31 | −$264,999 | −$124,007 | — |
| Q4 2020 | 2020-09-30 | −$833,184 | −$504,811 | — |
| Q3 2020 | 2020-06-30 | −$385,842 | $39,516 | — |
| Q2 2020 | 2020-03-31 | −$508,973 | −$117,651 | — |
| Q1 2020 | 2019-12-31 | −$140,992 | $296,448 | — |
| Q4 2019 | 2019-09-30 | −$328,373 | −$99,073 | — |
| Q3 2019 | 2019-06-30 | −$425,358 | $46,200 | — |
| Q2 2019 | 2019-03-31 | −$391,322 | $258,669 | — |
| Q1 2019 | 2018-12-31 | −$437,440 | −$306,814 | — |
| Q4 2018 | 2018-09-30 | −$229,300 | −$20,042 | — |
| Q3 2018 | 2018-06-30 | −$471,558 | −$123,830 | — |
| Q2 2018 | 2018-03-31 | −$649,991 | −$381,811 | — |
| Q1 2018 | 2017-12-31 | −$130,626 | $87,881 | — |
| Q4 2017 | 2017-09-30 | −$209,258 | $264,007 | — |
| Q3 2017 | 2017-06-30 | −$347,728 | $705,618 | — |
| Q2 2017 | 2017-03-31 | −$268,180 | $76,948 | — |
| Q1 2017 | 2016-12-31 | −$218,507 | $547,644 | — |
| Q4 2016 | 2016-09-30 | −$473,265 | −$305,466 | — |
| Q3 2016 | 2016-06-30 | −$1.1M | −$280,496 | — |
| Q2 2016 | 2016-03-31 | −$345,128 | $375,801 | — |
| Q1 2016 | 2015-12-31 | −$766,151 | $930,000 | — |
| Q4 2015 | 2015-09-30 | −$167,799 | — | — |
| Q3 2015 | 2015-06-30 | −$772,850 | — | — |
| Q2 2015 | 2015-03-31 | −$720,929 | — | — |
| Q1 2015 | 2014-12-31 | −$1.7M | — | — |
Hypha Labs ebitda trends
Over the last five reported fiscal years, Hypha Labs's ebitda increased from −$1.0M to −$946,314, a change of $97,359. The latest reported quarter, Q1 2023, shows −$71,577.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hypha Labs filings at SEC.gov ↗